FTRE Q2 2023 Earnings — Fortrea Holdings Inc. Revenue & Financial Results | Market Cap Arena

FTREFortrea Holdings Inc.

$851M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$725M-8.6% YoY

Gross Profit

$156M21.6% margin

Operating Income

$32M4.4% margin

Net Income

$31M4.2% margin

EPS (Diluted)

$0.32

QoQ Revenue Growth

+4.5%

Cash Flow

Operating Cash Flow

$150M

Free Cash Flow

$141M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$4.4B

Total Liabilities

$2.6B

Stockholders' Equity

$1.8B

Cash & Equivalents

$114M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$725M	$793M	-8.6%
Gross Profit	$156M	$155M	+0.6%
Operating Income	$32M	$84M	-62.5%
Net Income	$31M	$66M	-53.6%

Revenue Segments

Clinical Services Segment

$726M100%

Geographic Segments

North America

$438M55%

Europe

$200M25%

Other Geographical Areas

$155M20%